- NeuroQuant® PET
Rapid, automated regional quantification and Centiloid scoring of amyloid PET images
NeuroQuant® PET is a fully automated solution for quantifying amyloid PET images, with regional analysis and Centiloid scoring to support interpretation of recognized biomarkers.
FDA 510(k) CLEARED (K261916)
Standardized amyloid reporting and Centiloid quantification to support recognized biomarker interpretation
- Automatically quantifies amyloid PET tracer uptake localized to brain structures for regional SUVr reporting.
- Compatible with PET-MRI, PET-CT, or PET-only workflows.
- Centiloid quantification for comparison across amyloid tracers and over time.
Benefits
Reporting options
Amyloid tracer reporting and regions of interest
Clear visualization
Fusion images and anatomical overlays
Automated processing
Automated cloud-based processing
NeuroQuant® PET reports
Powered by NeuroQuant® for trusted and proven brain segmentation analysis.
Florbetapir Report
The NeuroQuant PET Florbetapir Report automatically quantifies amyloid-based tracer bindings localized to brain structures. Visual and statistical comparisons of each normalized regional PET tracer value are then compared to normative population data. Centiloid value displayed in report.
Florbetaben Report
The NeuroQuant PET Florbetaben Report automatically quantifies amyloid-based tracer bindings localized to brain structures. Visual and statistical comparisons of each normalized regional PET tracer value are then compared to normative population data. Centiloid value displayed in report.
Flutemetamol Report
The NeuroQuant PET Fluemetamol Report automatically quantifies amyloid-based tracer bindings localized to brain structures. Visual and statistical comparisons of each normalized regional PET tracer value are then compared to normative population data. Centiloid value displayed in report.
- Research Applications
The following NeuroQuant® PET outputs are provided for Research Use Only. They have not been cleared or approved by the FDA.
- FDG Report — regional quantification of glucose metabolism.
- Flortaucipir (tau) Report — regional quantification of tau tracer uptake.
- Z-score reporting — comparison of regional values to a normative population.
RESEARCH USE ONLY — NOT FDA CLEARED
NeuroQuant® PET research reports
Powered by NeuroQuant® for trusted and proven brain segmentation analysis.
FDG Report
The NeuroQuant PET FDG Report automatically quantifies metabolic tracer bindings localized to brain structures. Visual and statistical comparisons of each normalized regional PET tracer value are then compared to normative population data.
Flortaucipir Report
The NeuroQuant PET Flortaucipir Report automatically quantifies amyloid-based tracer bindings localized to brain structures. Visual and statistical comparisons of each normalized regional PET tracer value are then compared to normative population data. Centiloid value displayed in report.
